Not medical advice. Talk to your provider before using any peptide. Full disclaimer
Peptide Schedule Research TeamReviewed Apr 7, 20269 Citations
Teduglutide (Gattex/Revestive) Dosage Calculator
Healing & Recovery · FDA Approved · Grade A · 2 h half-life · Injection
Teduglutide (Gattex/Revestive) Dosage
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50 mcg/kg | Daily |
| Moderate | 50 mcg/kg | Daily |
| Aggressive | 50 mcg/kg | Daily |
Cycle: No scheduled off period.
No syringe calculation for this route
Subcutaneous
Teduglutide (Gattex/Revestive) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 50 mcg/kg to 50 mcg/kg per administration, daily.
If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.
About Teduglutide (Gattex/Revestive)
Beginner, moderate, and aggressive dosing amounts with timing. Free to use.
Teduglutide (Gattex/Revestive) is the only FDA-approved GLP-2 analog for short bowel syndrome. The STEPS trial showed 63% of patients reduced parenteral nutrition needs at 24 weeks. Cost sits near $520K per year, and intestinal adaptation reverses if you stop treatment.
View side effects and safety warnings →
Quick-Start: How to Use Teduglutide (Gattex/Revestive)
- 1Pull one 5 mg teduglutide vial and the supplied 0.5 mL sterile water for injection from the refrigerator. Let both reach room temperature (about 15 minutes, or briefly hold the vial in your palm).
- 2Inject all 0.5 mL of sterile water into the vial. Gently roll between your palms for about 15 seconds. Do not shake. Let the vial stand for 30 seconds to allow complete dissolution.
- 3Calculate your dose based on body weight at 0.05 mg/kg/day. The reconstituted concentration is 10 mg/mL. A 50 kg patient needs 0.25 mL (25 units on a 100-unit insulin syringe). A 70 kg patient needs 0.35 mL (35 units). A 100 kg patient needs 0.5 mL (50 units), more than the 0.38 mL one vial can give (label section 2.6), so that dose takes two vials. For renal impairment (eGFR under 60), cut the dose in half: 0.025 mg/kg/day.
Teduglutide (Gattex/Revestive) Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50 mcg/kg | Daily |
| Moderate | 50 mcg/kg | Daily |
| Aggressive | 50 mcg/kg | Daily |
Teduglutide is supplied as a 5 mg lyophilized vial in 30-vial kits. Reconstitute with the 0.5 mL sterile water for injection included in the kit. Do not use bacteriostatic water. Gently roll the vial; do not shake. Let it sit 30 seconds before drawing.
That gives you a 10 mg/mL concentration. For a 70 kg patient at the standard 0.05 mg/kg/day dose, you need 3,500 mcg (3.5 mg), which is 0.35 mL or 35 units on a 100-unit insulin syringe. A 50 kg patient draws 25 units (2,500 mcg). A 100 kg patient needs 5,000 mcg (0.5 mL), but only 0.38 mL (3.8 mg) can be drawn from one vial (GATTEX label, section 2.6). At the standard dose, anyone over 76 kg needs more than 3.8 mg, so more than one vial; the prescriber says how many.
The non-obvious thing beginners miss: you must use each reconstituted vial within 3 hours. There are no preservatives. Don't prepare vials ahead of time. Bedtime dosing is the community favorite because it helps you sleep through the early abdominal bloating instead of sitting with it all day. Rotate injection sites across four abdominal quadrants; mark the quadrant on the vial if it helps you track rotation.
Dosing based on Gattex/Revestive (teduglutide) FDA Prescribing Information: 9 published references.View all sources →
Ask AI about this math
Cross-check your Teduglutide (Gattex/Revestive) reconstitution math with AI
Teduglutide (Gattex/Revestive) Cost
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Teduglutide (Gattex/Revestive) Pharmacokinetics
Pharmacokinetics: Active Dose Over Time
t½ = ~2 hours (1.3h in SBS patients; range 0.9-3h depending on body weight)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Related Tools
Frequently Asked Questions
How popular is Teduglutide (Gattex/Revestive)?
Emerging. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
Reddit: 10. Community mentions on Reddit: ~<10 (no research/performance community presence; rare disea.
292 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Low search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.